The company entered a new financing agreement for up to $250M in April 2026, explicitly to support increased expenses for commercial expansion and R&D pipeline activities.
Filing excerpt
On April 1, 2026, the Company, certain of its subsidiaries, as guarantors, and Blue Owl Capital Corporation, as administrative agent, entered into a new Financing Agreement (the “2026 Financing Agreement”) for an aggregate principal amount of up to $250.0 million...
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Regions named
sec-10qmarketExpansionGet every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/ef6e98dd-3582-4250-88a7-6b2c676826c2 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.
{
"signal_id": "ef6e98dd-3582-4250-88a7-6b2c676826c2",
"signal_type": "sec-10q",
"signal_subtype": "marketExpansion",
"detected_at": "2026-05-12T09:24:56.03+00:00",
"company": {
"name": "Caris Life Sciences",
"domain": "carislifesciences.com"
},
"data": {
"detail": "The company entered a new financing agreement for up to $250M in April 2026, explicitly to support increased expenses for commercial expansion and R&D pipeline activities. This influx of capital creates significant budget for sales, marketing, and clinical trial support vendors.",
"metrics": {
"timeframe": "current_year",
"dollar_context": "New financing agreement for commercial expansion and general corporate purposes",
"dollar_millions": 250
},
"summary": "Caris Life Sciences secures $250M in new financing to fund 2026 commercial expansion",
"excerpts": "On April 1, 2026, the Company, certain of its subsidiaries, as guarantors, and Blue Owl Capital Corporation, as administrative agent, entered into a new Financing Agreement (the “2026 Financing Agreement”) for an aggregate principal amount of up to $250.0 million...",
"relevance": 0.9,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000044/cai-20260331.htm",
"filing_date": "2026-05-08",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Scaling infrastructure needed",
"signal_category": "market",
"regions_mentioned": [
"US"
],
"vendors_mentioned": [
"Blue Owl Capital Corporation"
]
}
}
curl https://signals.autobound.ai/v1/signals/ef6e98dd-3582-4250-88a7-6b2c676826c2 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"carislifesciences.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.